Human Infection Due to Recombinant Vaccinia–Rabies Glycoprotein Virus
Charles E. Rupprecht, V.M.D., Ph.D., Leonard Blass, M.D., Kathy Smith, D.V.M., Lillian A. Orciari, M.S., Michael Niezgoda, M.S., Sylvia G. Whitfield, M.S., Robert V. Gibbons, M.D., Marta Guerra, D.V.M., Ph.D., and Cathleen A. Hanlon, V.M.D., Ph.D.
Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.
Rabies is a fatal viral disease transmitted from animals tohumans. It causes more than 35,000 human deaths per year.1 Successfulapplication of veterinary vaccines can eliminate canine rabiesin an area, but control of rabies in free-ranging carnivoresrequires other strategies, such as oral vaccination.2 Live viralvaccines containing modified live rabies or recombinant vaccinia–rabiesglycoprotein virus, placed in a bait, are used for disease controlin Europe and North America.2,3,4,5 In the United States, morethan 22 million doses of vaccinia–rabies glycoproteinvaccine were distributed from 1990 to 2000, mainly to controlrabies in raccoons in the eastern . . . [Full Text of this Article]
Case Report
Methods
Results
Discussion
Source Information
From the Centers for Disease Control and Prevention, Atlanta (C.E.R., L.A.O., M.N., S.G.W., R.V.G., M.G., C.A.H.); Trumbull Memorial Hospital, Warren, Ohio (L.B.); and the Ohio Department of Health, Columbus (K.S.).
Address reprint requests to Dr. Rupprecht at the Rabies Section, Centers for Disease Control and Prevention, Mailstop G-33, 1600 Clifton Rd., N.E., Atlanta, GA 30333, or at cyr5@cdc.gov.
References
This article has been cited by other articles:
Faber, M., Faber, M.-L., Li, J., Preuss, M. A. R., Schnell, M. J., Dietzschold, B.
(2007). Dominance of a Nonpathogenic Glycoprotein Gene over a Pathogenic Glycoprotein Gene in Rabies Virus. J. Virol.
81: 7041-7047
[Abstract][Full Text]
Finnegan, C. J, Brookes, S. M, Johnson, N., Smith, J., Mansfield, K. L, Keene, V. L, McElhinney, L. M, Fooks, A. R
(2002). Rabies in North America and Europe. JRSM
95: 9-13
[Full Text]
A correction has been published: N Engl J Med 2001;345(24):1784.
Previous
